Kane Biotech Records Significant Online Sales Growth from Amazon

- November 9th, 2018

Kane Biotech (TSXV:KNE, OTCQB:KNBIF) announced that it has experienced significant year-over-year growth in online sales of its bluestem brand of oral care products on Amazon. As quoted in the press release: Combined sales on Amazon.com and Amazon.ca for October 2018 were $13,341 compared to $2,757 in October 2017, representing a 384% increase. For the year … Continued

Kane Biotech (TSXV:KNE, OTCQB:KNBIF) announced that it has experienced significant year-over-year growth in online sales of its bluestem brand of oral care products on Amazon.

As quoted in the press release:

Combined sales on Amazon.com and Amazon.ca for October 2018 were $13,341 compared to $2,757 in October 2017, representing a 384% increase. For the year to date (YTD), Kane Biotech recorded $82,245 through October 2018 compared to $18,299 for the same period in 2017, representing a 349% increase. All amounts referenced herein are in Canadian dollars.

Marc Edwards, Kane Biotech’s Chief Executive Officer, stated, “We’re very proud to announce this exciting news illustrating the value and benefits our customers are realizing through our impactful product line. Not only can we demonstrate proven efficacy and safety through independent, third party clinical trials, but we’ll soon have the most comprehensive lineup of oral care products in the market, providing customers a truly optimal oral hygiene program for their pets. The fact that all of our products have also been notified under Health Canada’s Notification Program for Veterinary Health Products (VHP), a key regulatory acknowledgement of their safety profile, just adds to that customer confidence.”

Click here to read the full press release.

Get the latest Biotech Investing stock information

Get the latest information about companies associated with Biotech Investing Delivered directly to your inbox.

Biotech Investing

Select None
Select All

Leave a Reply